Immunotherapy and Biomarkers in Neurodegenerative Disorders /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Humana,
2016.
|
| Edición: | 1st ed. 2016. |
| Colección: | Methods in Pharmacology and Toxicology,
|
| Materias: |
Tabla de Contenidos:
- Immunotherapy Against Amyloid-β in Alzheimer’s Disease: An Overview
- Active Immunization Against the Amyloid-β Peptide
- Immunotherapy Against N-Truncated Amyloid-β Oligomers
- Immunotherapy Against Amyloid-β Protofibrils: Opportunities and Challenges
- Immunotherapy Against α-Synuclein Pathology
- Extracellular α-Synuclein as a Target for Immunotherapy
- Immunotherapy of Parkinson’s Disease
- Tau Immunotherapy
- Active and Passive Immunotherapy Against Tau: Effects and Potential Mechanisms
- Immunotherapy on Experimental Models for Huntington’s Disease
- Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
- Volumetric MRI as a Diagnostic Tool in Alzheimer's Disease
- PET Imaging as a Diagnostic Tool in Alzheimer´s Disease
- Αlpha-Synuclein as a Diagnostic Biomarker for Parkinson’s Disease
- Imaging as a Diagnostic Tool in Parkinson’s Disease
- Mass Spectrometry-Based Proteomics in Biomarker Discovery for Neurodegenerative Diseases.